MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET 2019-2028

Lifesciences | Pharmaceuticals

MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET 2019-2028

Market by Type, Technology, Age Group, Delivery Mode and Geography | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

A Triton Market Research report has determined that the influenza vaccines market in the Middle East and Africa is set to surge at CAGR of 6.18% during the projected period 2019-2028.



Report scope can be customized per your requirements. Request For Customization

The countries scrutinized in the Middle East and Africa market are:

           Saudi Arabia

           United Arab Emirates

           Turkey

           South Africa

           Rest of Middle East & Africa

According to the Dubai government, the influenza vaccine immunization program is scheduled to offer a yearly influenza vaccine to infants older than six months, all children, adolescents and adults. The aging population and people suffering from diseases like diabetes, chronic pulmonary or cardiac diseases and chronic renal dysfunction must be given priority. Vaccination must also be prioritized for women after the first trimester of their pregnancy and for travelers traveling to a current outbreak area. Besides, for the household contacts of people in the high-risk group as well, vaccination is a suitable strategy. All these developmental strategies are indicating the growth of the influenza vaccines market in the UAE.

In Turkey, around 4.6% of the total GDP is spent on the healthcare sector. The central budget allocates approximately $15 billion for healthcare services. According to data provided by OECD (Organisation for Economic Co-operation and Development), the country’s healthcare expenditure per capita reached about $857, which is a 3.5 times rise since 2002. All these dedicated efforts by the government towards the development of the healthcare system are set to improve the demand for the influenza vaccines market in the country. This will help in the growth of the Turkish market.

Abbott is a healthcare company that is specialized in medical devices, diagnostics, nutritionals and generic medicines. The company is an expert in glucose monitoring, adult nutrition, blood and plasma screening, pediatric nutrition, point of care testing and remote heart failure monitoring. It offers different chronic pain devices and heart pumps.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.2.1.   QUADRIVALENT IS THE DOMINANT TYPE OF INFLUENZA VACCINE

2.2.2.   INJECTION IS FASTEST-GROWING DELIVERY MODE

2.2.3.   CELL-BASED TECHNOLOGY IS RAPIDLY GROWING TECHNOLOGY IN THE MARKET

2.2.4.   ADULT AGE GROUP IS MAJORLY CONTRIBUTING IN THE MARKET

2.3. PORTER’S FIVE FORCE ANALYSIS

2.3.1.   THREAT OF NEW ENTRANTS

2.3.2.   THREAT OF SUBSTITUTE

2.3.3.   BARGAINING POWER OF SUPPLIERS

2.3.4.   BARGAINING POWER OF BUYERS

2.3.5.   INTENSITY OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. MARKET DRIVERS

2.6.1.   ADVANCEMENT IN TECHNOLOGY

2.6.2.   INITIATIVES TAKEN UP BY THE GOVERNMENT

2.7. MARKET RESTRAINTS

2.7.1.   HIGH COST OF DEVELOPMENT

2.8. MARKET OPPORTUNITIES

2.8.1.   GROWTH IN THE CASES OF INFLUENZA

2.9. MARKET CHALLENGES

2.9.1.   COMPLEX DEVELOPMENT PROCESS

3.    INFLUENZA VACCINES MARKET OUTLOOK - BY TYPE

3.1. QUADRIVALENT VACCINE

3.2. TRIVALENT VACCINE

4.    INFLUENZA VACCINES MARKET OUTLOOK - BY TECHNOLOGY

4.1. EGG-BASED TECHNOLOGY

4.2. CELL-BASED TECHNOLOGY

5.    INFLUENZA VACCINES MARKET OUTLOOK - BY AGE GROUP

5.1. PEDIATRIC AGE GROUP

5.2. ADULT AGE GROUP

6.    INFLUENZA VACCINES MARKET OUTLOOK - BY DELIVERY MODE

6.1. INJECTION

6.2. NASAL SPRAY

7.    INFLUENZA VACCINES MARKET – MIDDLE EAST AND AFRICA

7.1. THE UNITED ARAB EMIRATES

7.2. TURKEY

7.3. SAUDI ARABIA

7.4. SOUTH AFRICA

7.5. REST OF MIDDLE EAST & AFRICA

8.    COMPETITIVE LANDSCAPE

8.1. MERCK SHARP & DOHME CORP

8.2. NOVARTIS AG

8.3. PFIZER INC

8.4. SANOFI

8.5. BIODIEM

8.6. EMERGENT BIOSOLUTIONS INC

8.7. F. HOFFMANN-LA ROCHE LTD

8.8. GLAXOSMITHKLINE PLC

8.9. ABBOTT

8.10. CSL LIMITED

9.    RESEARCH METHODOLOGY & SCOPE

9.1. RESEARCH SCOPE & DELIVERABLES

9.1.1.   OBJECTIVES OF STUDY

9.1.2.   SCOPE OF STUDY

9.2. SOURCES OF DATA

9.2.1.   PRIMARY DATA SOURCES

9.2.2.   SECONDARY DATA SOURCES

9.3. RESEARCH METHODOLOGY

9.3.1.   EVALUATION OF PROPOSED MARKET

9.3.2.   IDENTIFICATION OF DATA SOURCES

9.3.3.   ASSESSMENT OF MARKET DETERMINANTS

9.3.4.   DATA COLLECTION

9.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD        

TABLE 3: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)        

TABLE 4: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)

TABLE 5: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY AGE GROUP, 2019-2028 (IN $ MILLION)

TABLE 6: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY DELIVERY MODE, 2019-2028 (IN $ MILLION)

TABLE 7: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)

List of Figures

FIGURE 1: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY SOURCE, 2019 & 2028 (IN %)  

FIGURE 2: MIDDLE EAST AND AFRICA QUADRIVALENT INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 3: MIDDLE EAST AND AFRICA INJECTION DELIVERY MODEL MARKET, 2019-2028 (IN $ MILLION)  

FIGURE 4: MIDDLE EAST AND AFRICA CELL BASED TECHNOLOGY MARKET, 2019-2028 (IN $ MILLION)      

FIGURE 5: MIDDLE EAST AND AFRICA ADULT AGE GROUP MARKET, 2019-2028 (IN $ MILLION)      

FIGURE 6: PORTER’S FIVE FORCE ANALYSIS        

FIGURE 7: MARKET ATTRACTIVENESS INDEX       

FIGURE 8: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY QUADRIVALENT VACCINE, 2019-2028 (IN $ MILLION)    

FIGURE 9: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY TRIVALENT VACCINES, 2019-2028 (IN $ MILLION) 

FIGURE 10: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY EGG-BASED TECHNOLOGY, 2019-2028 (IN $ MILLION)      

FIGURE 11: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY CELL-BASED TECHNOLOGY, 2019-2028 (IN $ MILLION)      

FIGURE 12: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY PEDIATRIC AGE GROUP, 2019-2028 (IN $ MILLION)          

FIGURE 13: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY ADULT AGE GROUP, 2019-2028 (IN $ MILLION)       

FIGURE 14: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY INJECTION, 2019-2028 (IN $ MILLION)

FIGURE 15: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, BY NASAL SPRAY, 2019-2028 (IN $ MILLION)

FIGURE 16: MIDDLE EAST AND AFRICA INFLUENZA VACCINES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)  

FIGURE 17: THE UNITED ARAB EMIRATES INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)

FIGURE 18: TURKEY INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)    

FIGURE 19: SAUDI ARABIA INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)    

FIGURE 20: SOUTH AFRICA INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)  

FIGURE 21: REST OF MIDDLE EAST & AFRICA INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)        

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;